Skip to main content

Hassanein Waleed H's Form 4 filing

TransMedics Group, Inc. (TMDX) · filed Aug 23, 2024

Accession no.
0000950170-24-100208
Filed
Aug 23, 2024
Trade date
Aug 21-22, 2024
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $7.80M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hassanein Waleed HCIK 0001430466Director, Officer (President & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 21, 2024Common StockMOption exerciseAcquired+20,000$16.00+$320,00081,643Direct
Aug 21, 2024Common StockSSaleDisposed−20,000$171.03−$3,420,60061,643Direct
Aug 22, 2024Common StockMOption exerciseAcquired+25,000$16.14+$403,50086,643Direct
Aug 22, 2024Common StockSSaleDisposed−25,000$175.00−$4,375,00061,643Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 21, 2024Common StockMOption exerciseDisposed−20,000$0.00$0265,714Direct
Aug 22, 2024Common StockMOption exerciseDisposed−25,000$0.00$0153,000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)